GP Act III Acquisition Net Income
| GPAT Stock | 10.76 0.02 0.19% |
As of the 17th of February 2026, GP Act owns the Downside Deviation of 0.1953, market risk adjusted performance of 2.12, and Variance of 0.0127. GP Act III Acquisition technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from GP Act's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting GP Act's valuation are summarized below:There are currently eighty-eight fundamental measures for GP Act that can be evaluated and compared over time across peers in the sector. All traders should confirm GP Act's latest fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Income | 10 M | 10.5 M | |
| Net Income From Continuing Ops | 10 M | 10.5 M | |
| Net Income Per Share | 0.22 | 0.23 |
GPAT | Net Income | Build AI portfolio with GPAT Stock |
The evolution of Net Income for GP Act III Acquisition provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how GP Act compares to historical norms and industry peers.
Latest GP Act's Net Income Growth Pattern
Below is the plot of the Net Income of GP Act III Acquisition over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in GP Act III financial statement analysis. It represents the amount of money remaining after all of GP Act III Acquisition operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is GP Act's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GP Act's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 8.67 M | 10 Years Trend |
|
Net Income |
| Timeline |
GPAT Net Income Regression Statistics
| Arithmetic Mean | 1,705,695 | |
| Geometric Mean | 21,563 | |
| Coefficient Of Variation | 224.61 | |
| Mean Deviation | 2,823,430 | |
| Median | (3,973) | |
| Standard Deviation | 3,831,236 | |
| Sample Variance | 14.7T | |
| Range | 10.5M | |
| R-Value | 0.66 | |
| Mean Square Error | 8.8T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 503,574 | |
| Total Sum of Squares | 234.9T |
GPAT Net Income History
Other Fundumenentals of GP Act III
GPAT Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for GP Act is extremely important. It helps to project a fair market value of GPAT Stock properly, considering its historical fundamentals such as Net Income. Since GP Act's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GP Act's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GP Act's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Diversified Financial Services market expansion? Will GPAT introduce new products? Factors like these will boost the valuation of GP Act. Market participants price GPAT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about GP Act listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GP Act III is measured differently than its book value, which is the value of GPAT that is recorded on the company's balance sheet. Investors also form their own opinion of GP Act's value that differs from its market value or its book value, called intrinsic value, which is GP Act's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because GP Act's market value can be influenced by many factors that don't directly affect GP Act's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GP Act's value and its price as these two are different measures arrived at by different means. Investors typically determine if GP Act is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GP Act's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
GP Act 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GP Act's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GP Act.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in GP Act on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding GP Act III Acquisition or generate 0.0% return on investment in GP Act over 90 days. GP Act is related to or competes with Principal Financial, KeyCorp, Ares Capital, Apollo Global, Fifth Third, Brookfield Wealth, and Galaxy Digital. GP Act is entity of United States. It is traded as Stock on NASDAQ exchange. More
GP Act Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GP Act's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GP Act III Acquisition upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1953 | |||
| Information Ratio | (0.49) | |||
| Maximum Drawdown | 0.8433 | |||
| Value At Risk | (0.09) | |||
| Potential Upside | 0.1869 |
GP Act Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GP Act's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GP Act's standard deviation. In reality, there are many statistical measures that can use GP Act historical prices to predict the future GP Act's volatility.| Risk Adjusted Performance | 0.0401 | |||
| Jensen Alpha | 0.0041 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | (0.29) | |||
| Treynor Ratio | 2.11 |
GP Act February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0401 | |||
| Market Risk Adjusted Performance | 2.12 | |||
| Mean Deviation | 0.0648 | |||
| Downside Deviation | 0.1953 | |||
| Coefficient Of Variation | 793.55 | |||
| Standard Deviation | 0.1128 | |||
| Variance | 0.0127 | |||
| Information Ratio | (0.49) | |||
| Jensen Alpha | 0.0041 | |||
| Total Risk Alpha | (0) | |||
| Sortino Ratio | (0.29) | |||
| Treynor Ratio | 2.11 | |||
| Maximum Drawdown | 0.8433 | |||
| Value At Risk | (0.09) | |||
| Potential Upside | 0.1869 | |||
| Downside Variance | 0.0381 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.17) | |||
| Skewness | 0.4754 | |||
| Kurtosis | 5.76 |
GP Act III Backtested Returns
Currently, GP Act III Acquisition is very steady. GP Act III retains Efficiency (Sharpe Ratio) of 0.15, which attests that the entity had a 0.15 % return per unit of price deviation over the last 3 months. We have found twenty-eight technical indicators for GP Act, which you can use to evaluate the volatility of the firm. Please check out GP Act's Variance of 0.0127, downside deviation of 0.1953, and Market Risk Adjusted Performance of 2.12 to validate if the risk estimate we provide is consistent with the expected return of 0.0172%. GP Act has a performance score of 11 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.002, which attests to not very significant fluctuations relative to the market. As returns on the market increase, GP Act's returns are expected to increase less than the market. However, during the bear market, the loss of holding GP Act is expected to be smaller as well. GP Act III today owns a risk of 0.12%. Please check out GP Act III Acquisition standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if GP Act III Acquisition will be following its current price history.
Auto-correlation | 0.10 |
Insignificant predictability
GP Act III Acquisition has insignificant predictability. Overlapping area represents the amount of predictability between GP Act time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GP Act III price movement. The serial correlation of 0.1 indicates that less than 10.0% of current GP Act price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, GP Act III Acquisition reported net income of 8.67 M. This is 99.32% lower than that of the Financial Services sector and 98.29% lower than that of the Financials industry. The net income for all United States stocks is 98.48% higher than that of the company.
GPAT Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in net income category among its peers.
GP Act ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GP Act's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GP Act's managers, analysts, and investors.Environmental | Governance | Social |
GPAT Fundamentals
| Return On Equity | 0.0983 | ||||
| Return On Asset | -0.0014 | ||||
| Current Valuation | 386.94 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 100.00 % | ||||
| Number Of Shares Shorted | 3.43 K | ||||
| Price To Book | 1.33 X | ||||
| EBITDA | 8.67 M | ||||
| Net Income | 8.67 M | ||||
| Total Debt | 400 K | ||||
| Book Value Per Share | (0.40) X | ||||
| Cash Flow From Operations | (584.72 K) | ||||
| Short Ratio | 0.26 X | ||||
| Earnings Per Share | 0.34 X | ||||
| Market Capitalization | 386.69 M | ||||
| Total Asset | 297.47 M | ||||
| Retained Earnings | (13.93 M) | ||||
| Working Capital | 43.75 K | ||||
| Net Asset | 297.47 M |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.